Stay updated on Abatacept Post-marketing Clinical Trial in Japan
Sign up to get notified when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.

Latest updates to the Abatacept Post-marketing Clinical Trial in Japan page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRheumatoid arthritis was added as a main topic, and 'related topics' now include MedlinePlus Genetics. The page revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded “Ono Pharmaceutical Co., Ltd.” and removed “Rheumatoid arthritis” related topics including MedlinePlus Genetics and a differently formatted Ono Pharmaceutical Co. Ltd entry.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.5.2 was added, replacing the previous v3.5.0.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved related-topic links for Rheumatoid Arthritis and MedlinePlus Genetics from the Related Topics section. The core study content, including design, eligibility, and endpoints, remains unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedRheumatoid arthritis is added as a topic, MedlinePlus Genetics is listed as a related topic, and the revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Abatacept Post-marketing Clinical Trial in Japan
Enter your email address, and we'll notify you when there's something new on the Abatacept Post-marketing Clinical Trial in Japan page.